Evergreen Theragnostics
Evergreen Theragnostics: A leading US-based CDMO specializing in radiopharmaceutical development and manufacturing.
Founded
2019Evergreen Theragnostics: A leading US-based CDMO specializing in radiopharmaceutical development and manufacturing.
Evergreen Theragnostics, founded in 2019, is a leading US-based Contract Development and Manufacturing Organization (CDMO) specializing in radiopharmaceuticals. The company's core mission is to advance the development and manufacturing of theragnostic radiopharmaceuticals, combining therapy and diagnostics to improve patient outcomes. Their services include radiochemistry development, early-stage manufacturing, and analytical method optimization. Evergreen Theragnostics operates a state-of-the-art, nearly 14,000 square foot facility in Springfield, NJ, focusing on quality, innovation, and trust to serve patients and clients.
Notable affiliated individuals include experts with extensive experience in radiopharmaceutical commercialization and manufacturing process development. Evergreen Theragnostics has garnered significant attention for its contributions to the field of theragnostics, leveraging its advanced facility and specialized expertise to meet the growing demand for radiopharmaceuticals. Their impact is reflected in their commitment to enhancing patient care through innovative solutions and reliable manufacturing practices.
Companies similar to Evergreen Theragnostics include Illumina Radiopharmaceuticals, Nucleus RadioPharma, Radiomedix and TheraCea Pharma.
Evergreen Theragnostics was founded in 2019.
Evergreen Theragnostics' headquarters is located in Springfield Township, NJ, US.
Evergreen Theragnostics' most recent funding round was for $15M (USD) in March 2023.
As of Mar 13, 2023, Evergreen Theragnostics has raised a total of $34M (USD).
Evergreen Theragnostics has 27 employees as of Feb 5, 2024.
Radiomedix
radiomedix.com
